TOOL DEVELOPMENT TO ASSESS NAUSEA AND VOMITING AMONG PATIENTS RECEIVING CHEMOTHERAPY

The purpose of this study was to develop a psychometrically valid and reliable tool to assess nausea and vomiting among patients with cancer who receive chemotherapy treatment. Nausea and vomiting are considered the most common side effects for chemotherapy treatment. Several tools are available in the literature to assess nausea and vomiting, but it lacks the thorough measure of these symptoms. This has led to the development of a new tool, which combined all important assessment elements for nausea and vomiting. Standardized steps for developing the tool were followed, which include; explicating the objectives, blueprinting, and tool construction. The constructed tool has 24 items in which captures all the characteristics of nausea and vomiting. Cronbach's alpha for this tool is 0.97. The content validity index is 0.88. The concurrent validity with Rhodes Index of Nausea, Vomiting, and Retching (INVR) was established